|
⚲
|
| Keyboard |
| Nikolaou Anastasis
✚
|
|
|---|---|
| CIK # | 0001954186 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001954186] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Nikolaou Anastasis | |
| Acrivon Therapeutics Inc | |
| Hadjimichael Andreas | |
| Chione Ltd | |
| Czernik Marcin | |
| Smolokowski Wiaczeslaw |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2023-06-26 | Sell | 16 | $12.93 | 207 |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2023-06-15 | Sell | 2,056 | $12.14 | 24,960 |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2023-06-14 | Sell | 893 | $12.13 | 10,832 |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2023-06-13 | Sell | 3,000 | $12.30 | 36,900 |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2023-06-12 | Sell | 2,000 | $12.34 | 24,680 |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2022-11-17 | Buy | 400,000 | $12.50 | 5,000,000 |
|
Acrivon Therapeutics Inc ACRV
Series B Preferred Stock · derivative
|
2022-11-17 | Conversion | 26,281 | $0.00 | |
|
Acrivon Therapeutics Inc ACRV
Series A-1 Preferred Stock · derivative
|
2022-11-17 | Conversion | 8,497,692 | $0.00 | |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2022-11-17 | Conversion | 3,445,940 | ||
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2022-11-17 | Conversion | 10,657 |